Grail GRAL
NASDAQ GRAL
$80.77 +0.82 (+1.03%)
At close: Sep 18, 2026 · 4:00 PM EDT

Grail (GRAL) EBIT Margin Growth (1y) (2024 - 2026)

Analysis

Grail (GRAL) EBIT Margin Growth (1y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 1,012.00
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn -78.00
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 92.00
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 731.00
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn -21.00
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 2,013.00
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 97.00
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 747.00
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 2,048.00
10 Grail 3.61 Bn 2.75 Bn 21.34 Mn 5,803.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,803.00
Mar 31, 2026 14,960.00
Sep 30, 2025 29,430.00
Jun 30, 2025 468,693.00
Mar 31, 2025 36,862.00
Dec 31, 2024 -14,779.00
Sep 30, 2024 376,254.00
Jun 30, 2024 -422,206.00